As of 2025-12-13, the Relative Valuation of Bioventus Inc (BVS) is 4.90 USD. This relative valuation is based on P/E multiples. With the latest stock price at 7.55 USD, the upside of Bioventus Inc based on Relative Valuation is -35.0%.
The range of the Relative Valuation is 3.25 - 6.39 USD.
| Range | Selected | |
| Trailing P/E multiples | 54.8x - 67.6x | 64.5x |
| Forward P/E multiples | 34.4x - 47.4x | 39.3x |
| Fair Price | 3.25 - 6.39 | 4.90 |
| Upside | -56.9% - -15.4% | -35.0% |
| Date | P/E |
| 2025-12-11 | 78.52 |
| 2025-12-10 | 79.36 |
| 2025-12-09 | 76.08 |
| 2025-12-08 | 76.08 |
| 2025-12-05 | 75.02 |
| 2025-12-04 | 80.63 |
| 2025-12-03 | 80.10 |
| 2025-12-02 | 80.00 |
| 2025-12-01 | 80.42 |
| 2025-11-28 | 80.32 |
| 2025-11-26 | 80.95 |
| 2025-11-25 | 82.43 |
| 2025-11-24 | 78.41 |
| 2025-11-21 | 76.61 |
| 2025-11-20 | 69.10 |
| 2025-11-19 | 71.11 |
| 2025-11-18 | 73.97 |
| 2025-11-17 | 74.71 |
| 2025-11-14 | 77.78 |
| 2025-11-13 | 80.10 |
| 2025-11-12 | 80.95 |
| 2025-11-11 | 81.48 |
| 2025-11-10 | 79.26 |
| 2025-11-07 | 78.83 |
| 2025-11-06 | 79.15 |
| 2025-11-05 | 78.09 |
| 2025-11-04 | 79.89 |
| 2025-11-03 | 69.42 |
| 2025-10-31 | 69.31 |
| 2025-10-30 | 71.64 |
| 2025-10-29 | 71.64 |
| 2025-10-28 | 73.44 |
| 2025-10-27 | 71.00 |
| 2025-10-24 | 73.44 |
| 2025-10-23 | 73.65 |
| 2025-10-22 | 75.24 |
| 2025-10-21 | 75.34 |
| 2025-10-20 | 74.07 |
| 2025-10-17 | 70.47 |
| 2025-10-16 | 72.80 |
| 2025-10-15 | 73.33 |
| 2025-10-14 | 70.69 |
| 2025-10-13 | 69.52 |
| 2025-10-10 | 68.89 |
| 2025-10-09 | 69.73 |
| 2025-10-08 | 71.53 |
| 2025-10-07 | 70.37 |
| 2025-10-06 | 71.85 |
| 2025-10-03 | 74.28 |
| 2025-10-02 | 71.00 |